Certified by Founder Lodge
Manifold Bio
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $40,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
A next-generation protein therapeutics company pioneering an in vivo biologics design platform. By redesigning in vivo measurement to be available from day one, Manifold Bio has an advantage
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 14 ,2022 | Series A | $40,000,000 |
Playground Global
Section 32
Horizons Ventures
Triatomic Capital
Fifty Years
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Jupid | $840,000 | (May 1, 2026)
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
